NDRA · ENDRA Life Sciences Inc.

Substantial doubt about the company's ability to continue as a going concern.

“The Company has not established an ongoing source of revenue sufficient to cover its operating costs and to allow it to continue as a going concern and will require additional financing to fund its future planned operations, including research and development and commercialization of its products. These matters raise substantial doubt about the Company's ability to continue as going concern.”